000			02048nam a22003375i 4500
001			315317
003			MX-SnUAN
005			20160429160837.0
007			cr nn 008mamaa
008			160108s2014 xxu| s |||| 0|eng d
020			_a9781493903986 _9978-1-4939-0398-6
035			_avtls000415267
039		9	_y201601081102 _zstaff
050		4	_aQP34-38
245	1	4	_aThe multiple therapeutic targets of a20 / _cedited by Christiane Ferran.
264		1	_aNew York, NY : _bSpringer New York : _bSpringer, _c2014.
300			_axxi, 188 páginas :
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
490	0		_aAdvances in Experimental Medicine and Biology, _x0065-2598
500			_aSpringer eBooks
505	0		_aA20—A Bipartite Ubiquitin Editing Enzyme with Immunoregulatory Potential -- The Biology of A20-Binding Inhibitors of NF- ?B Activation (Abins) -- The Biology of A20-Like Molecules -- Anti-Viral Tetris: Modulation of the Innate Anti-Viral Immune Response by A20 -- A20 Expressing Tumors and Anticancer Drug Resistance -- Translational Studies of A20 in Atherosclerosis and Cardiovascular Disease -- A Biomarker of Allograft Outcome: A Showcase in Kidney Transplantation -- A20—An Omnipotent Protein in the Liver: Prometheus Myth Resolved? -- Emerging Roles for A20 in Islet Biology and Pathology -- Single Nucleotide Polymorphisms at the TNFAIP3/A20 Locus and Susceptibility/Resistance to Inflammatory and Autoimmune Diseases.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700	1		_aFerran, Christiane, _eeditor. _9357997
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9781493903979
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-1-4939-0398-6 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c315317 _d315317